Inventor · disambiguated record
Michael Trunk
Also filed as: TRUNK MICHAEL · TRUNK MICHAEL J F · TRUNK MICHAEL JOSEF FRIEDRICH
12 granted patents·26 pending applications·373 citations·filing 2001–2017
92Inventor score
Files withBOEHRINGER INGELHEIM INT18BOEHRINGER INGELHEIM PHARMA15TRUNK MICHAEL2HARTIG MAREKE1RASENACK NORBERT1
Top patents by PatentIndex Score
38 records- 0197US6908928B2Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jun 21, 2005·93 cites·23 claims
- 0297US6777423B2Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 17, 2004·128 cites·16 claims
- 0393US7462367B2Anticholinergic powder formulations for inhalationBOEHRINGER INGELHEIM INT·Filed 2004·Granted Dec 9, 2008·52 cites·30 claims
- 0489US7309707B2Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicamentBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Dec 18, 2007·44 cites·9 claims
- 0589US6900317B2Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing themBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted May 31, 2005·28 cites·20 claims
- 0686US8197845B2Encapsulated tiotropium containing powder formulation for inhalationHARTIG MAREKE·Filed 2009·Granted Jun 12, 2012·10 cites·4 claims
- 0782US7642268B2Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicamentBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Jan 5, 2010·3 cites·9 claims
- 0879US6881422B2Powder formulations containing tiotropium suitable for inhalationBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Apr 19, 2005·10 cites·14 claims
- 0977US7658949B2Surface modification of lactose excipient for use in powders for inhalationBOEHRINGER INGELHEIM INT·Filed 2005·Granted Feb 9, 2010·1 cites·10 claims
- 1072US7736628B2Powdered inhalants based on modified lactose mixtures as excipientBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jun 15, 2010·2 cites·24 claims
- 1172US2009137621A1Capsules Containing Inhalable TiotropiumBOEHRINGER INGELHEIM PHARMA·Filed 2008·Application pending·0 cites
- 1269US7763280B2Tiotropium containing powder formulation for inhalationBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jul 27, 2010·2 cites·2 claims
- 1364US2005084457A1Capsules containing inhalable tiotropiumBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 1463US2008038357A1Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation ThereofTRUNK MICHAEL·Filed 2007·Application pending·0 cites
- 1562US2006222599A1Inhalative powder formulations containing the CGRP-antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazineBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 1661US2007031347A1Powdered Medicaments Containing A Tiotropium Salt and Salmeterol XinafoateBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1761US2005042179A1Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazineBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 1860US2010055193A1Stable powder formulation containing an anticholinergic agentBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 1957US2005255050A1Powder formulations for inhalation, comprising enantiomerically pure beta agonistsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 2057US2004152720A1Powdered medicaments containing a tiotropium salt and salmeterol xinafoateBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 2155US2017326150A1Stable powder formulation containing an anticholingeric agentBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2255US2013164344A1Stable powder formulation containing an anticholingeric agentTRUNK MICHAEL·Filed 2012·Application pending·0 cites
- 2355US2004014679A1Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereofBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 2454US2005042180A1Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powderBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2553US2005043247A1Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalativeBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2653US2012034275A1Powder formulations for inhalation, comprising enantiomerically pure beta agonistsTRUNK MICHAEL JOSEF FRIEDRICH·Filed 2011·Application pending·0 cites
- 2753US2005042178A1Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powderBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2852US2005009857A1Powder formulations containing tiotropium suitable for inhalationBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 2952US2016263121A1Stable powder formulation containing an anticholingeric agentBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 3051US2004087793A1Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 3151US2005147568A1Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing themBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 3248US2010189780A1Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as CarrierBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 3347US2006134007A1Blister for inhalersBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 3446US2010047359A1Stable powder formulation containing a novel anticholinergic agentBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3544US2010233268A1Powder formulations for inhalation containing enantiomerically pure beta-agonistsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3644US2011061652A1Blister for inhalersBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3739US2010272638A1Radiolabelled microparticles, processes for the preparation thereof and the use thereofBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3835US9156835B2Micronization methodRASENACK NORBERT·Filed 2006·Granted Oct 13, 2015·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Michael Trunk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →